Department of Obstetrics, Gynecology and Reproductive Medicine, Pôle Femmes Parents Enfants, AP-HM La Conception University Hospital, 147 bd Baille, 13005, Marseille, France.
Méditerranean Network, Périnatality South and Corse, Network, 13015, Marseille, France.
J Gynecol Obstet Hum Reprod. 2021 May;50(5):102038. doi: 10.1016/j.jogoh.2020.102038. Epub 2020 Dec 8.
On March 14, 2020, France has entered into stage 3 of the COVID-19 pandemic. The French National Health Agency (Haute Autorité de Santé) has urgently recommended the use of medical abortion at home between 7 and 9 weeks of gestation and telemedicine for medical abortion consultations. The main objective of this study was to assess whether the emergency measures undertaken for the management of abortions during the COVID-19 pandemic led to practice changes, and to obtain practitioners' opinions regarding the continuation of these measures.
This was a retrospective, quantitative, online self-administered survey from August 6, 2020 to October 2, 2020, aimed at health workers performing abortions (midwives, general practitioners, gynecologists obstetricians and medical gynecologists) in the South and Corse regions in France.
Among the 124 practitioners included, 59/77 (76.6 %) offered medical abortion at home between 7 and 9 weeks of gestation and 61/89 (68.5 %) of them wished to carry on this practice. 55/123 (44.7 %) practitioners offered telemedicine for medical abortion at home and 71/115 (61.7 %) of them wished to carry on this practice.
The emergency measures implemented by the the French National Health Agency (Haute Autorité de Santé) for medical abortion are approved and followed by the majority of health workers performing abortions in the South and Corse regions. This measure may be extended out of the COVID-19 epidemic.
2020 年 3 月 14 日，法国进入 COVID-19 大流行第 3 阶段。法国国家卫生署（Haute Autorité de Santé）紧急建议在妊娠 7-9 周时在家中进行药物流产，并采用远程医疗进行药物流产咨询。本研究的主要目的是评估 COVID-19 大流行期间为管理流产而采取的紧急措施是否导致实践发生变化，并了解从业者对继续采取这些措施的意见。
这是一项回顾性、定量、在线自我管理调查，于 2020 年 8 月 6 日至 10 月 2 日在法国南部和科西嘉地区进行，对象为从事流产的卫生工作者（助产士、全科医生、妇科医生和妇科医生）。
在纳入的 124 名从业者中，59/77（76.6%）在妊娠 7-9 周时提供在家中进行药物流产，61/89（68.5%）希望继续开展这一实践。55/123（44.7%）从业者提供在家中进行药物流产的远程医疗，71/115（61.7%）希望继续开展这一实践。
法国国家卫生署（Haute Autorité de Santé）为药物流产实施的紧急措施得到了在法国南部和科西嘉地区进行流产的大多数卫生工作者的认可和遵循。这项措施可能会在 COVID-19 疫情之外继续实施。
